Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | SCN1A | P35498 | 1/20 | 0.67 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.67 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.67 |
| ▸ | EBP | Q15125 | 3/20 | 0.65 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.65 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | MCHR1 | Q99705 | 3/20 | 0.61 |
| ▸ | BCHE | P06276 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 4/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.55 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.55 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.55 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7246166 | 0.92 | MAPT (0.68) | MAPTLMNASCN1ASCN2ASCN3A | |
| SCHEMBL8184959 | 0.87 | EBP (0.54) | MAPTLMNASCN1ASCN2ASCN3A | |
| SCHEMBL29625647 | 0.87 | EBP (0.54) | MAPTLMNASCN1ASCN2ASCN3A | |
| SCHEMBL5410731 | 0.86 | LMNA (0.78) | MAPTLMNASCN1ASCN2ASCN3A | |
| Hydrochloric Acid SCHEMBL11672435 | 0.85 | LMNA (0.76) | MAPTLMNASCN1ASCN2ASCN3A | |
| SCHEMBL250102 | 0.84 | EBP (0.69) | MAPTLMNASCN1ASCN2ASCN3A | |
| SCHEMBL2953908 | 0.84 | MAPT (0.74) | MAPTRAB9ABCHEACHEESR1 | |
| SCHEMBL3149568 | 0.84 | EBP (0.69) | MAPTLMNASCN1ASCN2ASCN3A | |
| SCHEMBL1951546 | 0.83 | MAPT (1.00) | MAPTLMNARAB9AKMT2AKDM4E | |
| SCHEMBL10885211 | 0.83 | EBP (0.71) | MAPTLMNASCN1ASCN2ASCN3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642766-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-11-05 | — | — | EP | disclosed |
| US-12404243-B2 | Inhibitors of the Wnt/beta-catenin pathway | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-09-02 | — | — | US | disclosed |
| EP-3749640-B1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | UNIV CALIFORNIA (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024145585-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-07-04 | — | — | WO | disclosed |
| US-20240059654-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-02-22 | — | — | US | disclosed |
| US-11708329-B2 | Inhibitors of the WNT/beta-catenin pathway | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-07-25 | — | — | US | disclosed |
| US-20210371384-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-12-02 | — | — | US | disclosed |
| EP-3749640-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | The Regents of the University of California (US) | 2020-12-16 | — | — | EP | disclosed |
| WO-2019152536-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-08-08 | — | — | WO | disclosed |
| US-7582655-B2 | 1-[4-(2-Dimethylaminoethoxy)phenylcarbonyl]-3,5-bis(phenylmethylene)-4-piperidone hydrochloride; useful in reversing multidrug resistance | UNIVERSITY OF SASKATCHEWAN (CA) | 2009-09-01 | — | — | US | disclosed |
| EP-1960358-A1 | ANTINEOPLASTIC COMPOUNDS | University of Saskatchewan (CA) | 2008-08-27 | — | — | EP | disclosed |
| US-20070155733-A1 | 1-[4-(2-Dimethylaminoethoxy)phenylcarbonyl]-3,5-bis(phenylmethylene)-4-piperidone hydrochloride; useful in reversing multidrug resistance | UNIVERSITY OF SASKATCHEWAN (CA) | 2007-07-05 | — | — | US | disclosed |
| WO-2007059613-A1 | ANTINEOPLASTIC COMPOUNDS | UNIVERSITY OF SASKATCHEWAN (CA) | 2007-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708329-B2 | Inhibitors of the WNT/beta-catenin pathway | CTNNB1, CTNNBL1, CTNND1 | MAPT 3908/4885LMNA 3371/4885SCN1A 4309/4885 |
| US-12404243-B2 | Inhibitors of the Wnt/beta-catenin pathway | CTNNB1, CTNNBL1, CTNND1 | MAPT 3908/4885LMNA 3371/4885SCN1A 4309/4885 |
| US-20210371384-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | CTNNB1, CTNNBL1, CTNND1 | MAPT 3908/4885LMNA 3371/4885SCN1A 4309/4885 |
| US-20070155733-A1 | 1-[4-(2-Dimethylaminoethoxy)phenylcarbonyl]-3,5-bis(phenylmethylene)-4-piperidone hydrochloride; useful in reversing multidrug resistance | ABCC1, MCL1, SLC11A2 | MAPT 4706/4885LMNA 1083/4885SCN1A 1068/4885 |
| US-20240059654-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | CTNNB1, CTNNBL1, CTNND1 | MAPT 3908/4885LMNA 3371/4885SCN1A 4309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.